Detalles de la búsqueda
1.
Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.
Cost Eff Resour Alloc
; 10(1): 1, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22296830
2.
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK.
Eur J Health Econ
; 19(1): 21-35, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28093662
3.
Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review.
Medicine (Baltimore)
; 97(31): e11736, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30075584
4.
A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate.
CNS Drugs
; 30(10): 985-96, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530525
5.
A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities.
J Eval Clin Pract
; 17(2): 288-97, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21029268
6.
Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.
Int Clin Psychopharmacol
; 26(2): 63-8, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21088608
Resultados
1 -
6
de 6
1
Próxima >
>>